Chronic diseases driven by metabolic dysfunction

September 7, 2018, University of California - San Diego
Chronic diseases driven by metabolic dysfunction
False-color transmission electron micrograph of a mitochondrion inside a cell. Credit: Thomas Deerinck, National Center for Microscopy and Imaging Research, UC San Diego

Much of modern Western medicine is based upon the treatment of acute, immediate harm, from physical injury to infections, from broken bones and the common cold to heart and asthma attacks.

But progress in treating , where the cause of the problem is often unknown—and, in fact, may no longer even be present—has lagged. Chronic conditions like cancer, diabetes and cardiovascular disease defy easy explanation, let alone remedy. The Centers for Disease Control and Prevention estimate that more than half of adults and one-third of children and teens in the United States live with at least one chronic illness. Chronic medical conditions, according to the National Institutes of Health, cause more than half of all deaths worldwide.

In a new paper, available online in Mitochondrion in advance of publication, Robert K. Naviaux, MD, Ph.D., professor of medicine, pediatrics and pathology at University of California San Diego School of Medicine, posits that chronic disease is essentially the consequence of the natural healing cycle becoming blocked, specifically by disruptions at the metabolic and cellular levels.

"The is a dynamic circle that starts with injury and ends with recovery. The molecular features of this process are universal," said Naviaux, who also directs the Mitochondrial and Metabolic Disease Center at UC San Diego. "Emerging evidence shows that most chronic illnesses are caused by the biological reaction to an injury, not the initial injury or the agent of the injury. The illness occurs because the body is unable to complete the healing process."

For example, said Naviaux, melanoma—the deadliest form of skin cancer—can be caused by sun exposure that occurred decades earlier, damaging DNA that was never repaired. Post-traumatic stress disorder can flare months or years after the original head injury has healed. A concussion sustained before an earlier concussion has completely resolved typically results in more severe symptoms and prolonged recovery, even if the second impact is less than the first.

"Progressive dysfunction with recurrent injury after incomplete healing occurs in all organ systems, not just the brain," said Naviaux. "Chronic disease results when are caught in a repeating loop of incomplete recovery and re-injury, unable to fully heal. This biology is at the root of virtually every chronic illness known, including susceptibility to recurrent infections, autoimmune diseases like rheumatoid arthritis, diabetic heart and kidney disease, asthma, chronic obstructive pulmonary disease, Alzheimer's dementia, cancer and autism spectrum disorder."

For more than a decade, Naviaux and colleagues have been investigating and developing a theory based on cell danger response (CDR), a natural and universal cellular reaction to injury or stress. In the new paper, Naviaux describes the metabolic features of the three stages of CDR that comprise the healing cycle.

"The purpose of CDR is to help protect the cell and jump-start the healing process," said Naviaux, by essentially causing the cell to harden its membranes, cease interaction with neighbors and withdraw within itself until the danger has passed.

"But sometimes CDR gets stuck. At the molecular level, cellular equilibrium is altered, preventing completion of the healing cycle and permanently changing the way the cell responds to the world. When this happens, cells behave as if they are still injured or in imminent danger, even though the original cause of the injury or threat has passed."

Last year, Naviaux conducted a small, randomized clinical trial of 10 boys diagnosed with autism, treating them with a single dose of a century-old drug that inhibits adenosine triphosphate (ATP), a small molecule produced by cellular mitochondria that serves as a warning siren of danger. When the abnormal ATP signaling was silenced, the treated boys in the trial displayed dramatically improved communication and social behaviors. They spoke, made eye contact and ceased repetitive motions. But the benefits were transient, fading and disappearing as the drug exited their systems. Naviaux's team is preparing for a larger, longer trial in 2019.

In his new paper, Naviaux describes in detail how he, based on growing evidence, believes metabolic dysfunction drives chronic disease. Progression through the healing cycle, he said, is controlled by mitochondria—organelles within cells best known for their production of most of the energy cells need to survive—and metabokines, signaling molecules derived from metabolism to regulate cellular receptors, including more than 100 linked to healing.

"It's abnormalities in metabokine signaling that cause the normal stages of the cell danger response to persist abnormally, creating blocks in the healing cycle," said Navaiux, who noted CDR theory also explains why some people heal more quickly than others and why a chronic disease seemingly treated successfully can relapse. It's a form of metabolic "addiction" in which the recovering cell becomes conditioned to its impaired state.

Naviaux suggests science may be on the cusp of writing a second book of medicine, one that focuses on the prevention of chronic illness and new treatments for chronic that can help some people recover completely, where old approaches produced only small improvements with symptoms that persisted for life.

"The idea would be to direct treatments at the underlying processes that block the healing cycle," he said. "New treatments might only be given for a short period of time to promote healing, not unlike applying a cast to promote the healing of a broken leg. When the cast is removed, the limb is weak, but over time, muscles recover and bone that was once broken may actually be stronger."

"Once the triggers of a chronic have been identified and removed, and on-going symptoms treated, we need to think about fixing the underlying issue of impaired . By shifting the focus away from the initial causes to the metabolic factors and signaling pathways that maintain chronic illness, we can find new ways to not only end chronic illness but prevent it."

Explore further: Researchers studying century-old drug in potential new approach to autism

More information: Robert K. Naviaux. Metabolic features and regulation of the healing cycle—A new model for chronic disease pathogenesis and treatment, Mitochondrion (2018). DOI: 10.1016/j.mito.2018.08.001

Related Stories

Researchers studying century-old drug in potential new approach to autism

May 26, 2017
In a small, randomized Phase I/II clinical trial (SAT1), researchers at University of California San Diego School of Medicine say a 100-year-old drug called suramin, originally developed to treat African sleeping sickness, ...

Clinical trial launched to assess safety and efficacy of autism drug treatment

June 10, 2015
Researchers at the University of California, San Diego School of Medicine have launched a clinical trial to investigate the safety and efficacy of an unprecedented drug therapy for autism.

Single dose reverses autism-like symptoms in mice

June 17, 2014
In a further test of a novel theory that suggests autism is the consequence of abnormal cell communication, researchers at the University of California, San Diego School of Medicine report that an almost century-old drug ...

Newly identified target may help with drug discovery for chronic inflammatory diseases

July 25, 2018
Inflammation is part of the body's natural healing process. But when it becomes chronic, inflammation can lead to cancer, Alzheimer's disease and other conditions. Inflammasomes—protein-based molecular machines—trigger ...

Unexpected helpers in wound healing

January 24, 2018
Nerve cells in the skin help wounds to heal. When an injury occurs, cells known as glial cells change into repair cells and disseminate into the wound, where they help the skin to regenerate, researchers from the University ...

Drug treatment corrects autism symptoms in mouse model

March 13, 2013
Autism results from abnormal cell communication. Testing a new theory, researchers at the University of California, San Diego School of Medicine have used a newly discovered function of an old drug to restore cell communications ...

Recommended for you

Why some human genes are more popular with researchers than others

September 18, 2018
Historical bias is a key reason why biomedical researchers continue to study the same 10 percent of all human genes while ignoring many genes known to play roles in disease, according to a study publishing September 18 in ...

Class of neurological disorders share 3-D genome folding pattern, study finds

September 18, 2018
In a class of roughly 30 neurological disorders that includes ALS, Huntington's Disease and Fragile X Syndrome, the relevant mutant gene features sections of repeating base pair sequences known as short tandem repeats, or ...

Researchers resolve decades-old mystery about the most commonly mutated gene in cancer

September 18, 2018
The most commonly mutated gene in cancer has tantalized scientists for decades about the message of its mutations. Although mutations can occur at more than 1,100 sites within the TP53 gene, they arise with greatest frequency ...

Study of one million people leads to world's biggest advance in blood pressure genetics

September 17, 2018
Over 500 new gene regions that influence people's blood pressure have been discovered in the largest global genetic study of blood pressure to date, led by Queen Mary University of London and Imperial College London.

Genetic mutations thwart scientific efforts to fully predict our future

September 17, 2018
Ever since the decoding of the human genome in 2003, genetic research has been focused heavily on understanding genes so that they could be read like tea leaves to predict an individual's future and, perhaps, help them stave ...

Gene therapy via skin protects mice from lethal cocaine doses

September 17, 2018
There are no approved medications to treat either cocaine addiction or overdose. Frequent users tend to become less and less sensitive to the drug, leading to stronger or more frequent doses. The typical result is addiction. ...

5 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

gzurbay
not rated yet Sep 07, 2018
In the case of chronic disease which seem to result from metabolites of dysbiosis it would seem the damage is the result of the continual actual exposure - that makes healing unlikely - or impossible. This begs the question of an examination of metabolites of common chronic disease that might shed some valuable light...

I have to wonder if the appendix is the bad actor, - acting as a reservoir of bad micro-biota....
Hyperfuzzy
not rated yet Sep 08, 2018
Is this a meta-bolic disease or is our metabolism a disease in stasis? Trying to understand what ya sa'ing
Whydening Gyre
not rated yet Sep 08, 2018
...
I have to wonder if the appendix is the bad actor, - acting as a reservoir of bad micro-biota....

Mine's removed. Where is the bad micro biota stored then?
(maybe the reason I don't get sick - it just passes thru)
Spaced out Engineer
not rated yet Sep 08, 2018
CDR for PDD healing. based on biological to Freudian theory, Belief in embedded embodied claims for features, pliancy with modality,, and tolerance for agency.
tekram
5 / 5 (1) Sep 09, 2018
The drug mentioned here in a clinical trial for treatment of autism spectrum disorder (ASD) by Naviaux is Suramin which is normally used for treatment of human sleeping sickness caused by trypanosomes. Suramin was discovered by Bayer scientists in 1916 and its formula kept secret for many years. Naviaux is hypothesizing that purinergic signaling from the release and metabolism of extracellular nucleotides plays an important role in all stages of the healing cycle and that using suramin as an anti-purinergic could stimulate the completion of the healing cycle by up-regulating metabokine signaling.

https://clinicalt...02508259

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.